Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|63||2013||Chairman of the Board and Director|
|60||2014||Chief Executive Officer, Chief Commercial Officer, Director|
|46||2015||Chief Financial Officer, Chief Accounting Officer|
|49||2014||Senior Vice President - Business Development, General Counsel, Secretary|
|61||2000||Vice President - U.S. Operations, General Manager|
- BRIEF-Vivus and Metuchen Pharmaceuticals announce license agreement for commercial rights to Stendra
- BRIEF-Vivus says extends return date of Stendra commercial rights
- BRIEF-Vivus posts qtrly rev $13.8 mln vs $23.0 mln last year
- BRIEF-Vivus says to extend return date of Stendra commercial rights
- BRIEF-Vivus receives notice from Hetero USA that it has filed with U.S. FDA ANDA for generic versions of all strengths of Stendra tablets